Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 31:11:201-210.
doi: 10.2174/1874364101711010201. eCollection 2017.

Genetics in Keratoconus - What is New?

Affiliations

Genetics in Keratoconus - What is New?

Sarah Moussa et al. Open Ophthalmol J. .

Abstract

Background: Keratoconus is characterized as a bilateral, progressive, non-inflammatory thinning of the cornea resulting in blurred vision due to irregular astigmatism. Keratoconus has a multifactorial etiology, with multiple genetic and environmental components contributing to the disease pathophysiology. Several genomic loci and genes have been identified that highlight the complex molecular etiology of this disease.

Conclusion: The review focuses on current knowledge of these genetic risk factors associated with keratoconus.

Keywords: Environmental risk factors; Genetics; Genomic loci; Irregular astigmatism; Keratoconus; Non-inflammatory.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Rabinowitz Y.S. Keratoconus. Surv. Ophthalmol. 1998;42(4):297–319. doi: 10.1016/S0039-6257(97)00119-7. - DOI - PubMed
    1. Stabuc-Silih M., Strazisar M., Ravnik-Glavac M., Hawlina M., Glavac D. Genetics and clinical characteristics of keratoconus. Acta Dermatovenerol. Alp. Panonica Adriat. 2010;19(2):3–10. - PubMed
    1. Krachmer J.H., Feder R.S., Belin M.W. Keratoconus and related noninflammatory corneal thinning disorders. Surv. Ophthalmol. 1984;28(4):293–322. doi: 10.1016/0039-6257(84)90094-8. - DOI - PubMed
    1. Jun AS, Cope L, Speck C, et al. Subnormal cytokine profile in the tear fluid of keratoconus patients. PLoS One. 2011;27(6):e16437. doi: 10.1371/journal.pone.0016437. - DOI - PMC - PubMed
    1. Lema I., Sobrino T., Durán J.A., Brea D., Díez-Feijoo E. Subclinical keratoconus and inflammatory molecules from tears. Br. J. Ophthalmol. 2009;93(6):820–824. doi: 10.1136/bjo.2008.144253. - DOI - PubMed

LinkOut - more resources